Connolly SJ, Pogue J, Eikelboom J, et al; ACTIVE W Investigators. Bene t of oral anticoagulant over antiplate- let therapy in atrial brillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation. 2008;118(20):2029-2037. 175. Wan Y, Heneghan C, Perera R, et al. Anticoagulation control and prediction of adverse events in patients with atrial bril- lation: a systematic review. Circ Cardiovasc Qual Outcomes. 2008;1(2):84-91.